Allspring Global Investments Holdings LLC decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 18.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 27,889 shares of the biopharmaceutical company’s stock after selling 6,492 shares during the period. Allspring Global Investments Holdings […]